Sclerosis: all 3,103 studies

Page 5 of 32. Open to participants first (314), then studies with results posted, then the rest; newest registration first within each.

• A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Systemic SclerosisCompletedNCT03798366Phase 2Results posted
• Collection of Blood Samples From Patients With Relapsing MS Who Developed ITP After Receiving LemtradaCompletedNCT03784898Phase 4Results posted
• Isokinetic Exercises in Patients With Multiple SclerosisCompletedNCT03779724Not applicableResults posted
• Vaginal Estriol in Multiple SclerosisCompletedNCT03774407Phase 2/3Results posted
• Safety and Tolerability of ISX (Isoxsuprine HCL) in MS RelapsesCompletedNCT03752307Phase 1/2Results posted
• Effects of Cladribine Tablets on the PK of Microgynon®CompletedNCT03745144Phase 1Results posted
• A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple SclerosisCompletedNCT03737851Phase 2Results posted
• A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple SclerosisCompletedNCT03737812Phase 2Results posted
• A Study to Evaluate Efficacy, Safety, and Tolerability of EID of Natalizumab (BG00002) in Participants With RRMS Switching From Treatment With Natalizumab SID in Relation to Continued SID Treatment- Followed by Extension Study Comprising SC and IV Natalizumab AdministrationCompletedNCT03689972Phase 3Results posted
• Riluzole Oral Soluble Film (ROSF) Swallowing Safety in Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT03679975Phase 2Results posted
• Exercise Training Effects on Cognition and Brain Function in Multiple Sclerosis: Project EXACTCompletedNCT03677440Not applicableResults posted
• Combined Effect of Transcranial Direct Current Stimulation (tDCS) and Physical Activity on Gait and Functional Mobility in Participants With Multiple SclerosisCompletedNCT03658668Not applicableResults posted
• A Positive Psychology Intervention for Patients With Multiple SclerosisCompletedNCT03637699Not applicableResults posted
• Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS PatientsCompletedNCT03623243Phase 3Results posted
• Cognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis FatigueCompletedNCT03621761Phase 4Results posted
• A Study to Evaluate the Safety of Administering Ocrelizumab Per a Shorter Infusion Protocol in Participants With Primary Progressive Multiple Sclerosis (PPMS) and Relapsing Multiple Sclerosis (RMS)CompletedNCT03606460Phase 3Results posted
• Cardiac Safe Transplants for Systemic SclerosisTerminatedNCT03593902Phase 2/3Results posted
• Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT03580616Phase 2Results posted
• Digital Cognition in Multiple SclerosisCompletedNCT03569618Not applicableResults posted
• A Safety and Efficacy Study of ADS-5102 in Patients With Multiple Sclerosis and Walking ImpairmentCompletedNCT03567057Phase 3Results posted
• Assessment of tDCS-Induced Neuronal Responses in Multiple Sclerosis (MS) With Advanced MRICompletedNCT03564496Not applicableResults posted
• Upper Extremity Function in Multiple Sclerosis Patients With Advanced Disability Treated With OcrevusCompletedNCT03562975Results posted
• A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS PatientsCompletedNCT03560739Phase 2Results posted
• Fatigue Management Programs for People With MSCompletedNCT03550170Not applicableResults posted
• Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.CompletedNCT03525834Phase 4Results posted
• The Scleroderma Patient-centered Intervention Network (SPIN) Support Group Leader Education Program Feasibility TrialCompletedNCT03508661Not applicableResults posted
• Ketamine for Treatment of MS FatigueCompletedNCT03500289Phase 1/2Results posted
• A Pilot Trial of Remotely-Supervised Transcranial Direct Current Stimulation (RS-tDCS) to Enhance Motor Learning in Progressive Multiple Sclerosis (MS)CompletedNCT03499314Not applicableResults posted
• Melatonin in Patients With Multiple Sclerosis (MS).CompletedNCT03498131Early Phase 1Results posted
• Arimoclomol in Amyotropic Lateral SclerosisCompletedNCT03491462Phase 3Results posted
• Comparative Effectiveness Study Telerehab Versus ConventionalCompletedNCT03468868Not applicableResults posted
• The Effect of RNS60 on ALS BiomarkersCompletedNCT03456882Phase 2Results posted
• Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking ImpairmentCompletedNCT03436199Phase 3Results posted
• A Trial of Bile Acid Supplementation in Patients With Multiple SclerosisCompletedNCT03423121Phase 1/2Results posted
• Carnosine Loading and Periodized Training in MS and HCCompletedNCT03418376Not applicableResults posted
• Meningeal Inflammation on 7T MRI as a Tool for Measuring and Predicting Ocrelizumab Response in Multiple SclerosisCompletedNCT03396822Results posted
• A Pilot Study in Participants With Relapsing Remitting Multiple Sclerosis (RR-MS)TerminatedNCT03387046Phase 2Results posted
• Evaluation of Quality of Life (QoL) in Subjects With Highly Active Relapsing Multiple Sclerosis (MS) (CLARIFY MS)CompletedNCT03369665Phase 4Results posted
• Evaluation of the Onset of Action in Highly Active MS (MAGNIFY)CompletedNCT03364036Phase 4Results posted
• Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple SclerosisCompletedNCT03355365Phase 2Results posted
• Mechanism of Action of Ocrelizumab in Multiple SclerosisCompletedNCT03344094Results posted
• Maximizing Outcome of Multiple Sclerosis TransplantationTerminatedNCT03342638Phase 3Results posted
• A Study to Evaluate the Long-term Safety of Arbaclofen Extended-Release Tablets for Patients With Spasticity Due to MSCompletedNCT03319732Phase 3Results posted
• Rehabilitative Trial With tDCS in Amyotrophic Lateral SclerosisCompletedNCT03293394Not applicableResults posted
• A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MSCompletedNCT03290131Phase 3Results posted
• Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS) ( ULTIMATE 1 )CompletedNCT03277261Phase 3Results posted
• Study to Assess the Efficacy and Safety of Ublituximab in Participants With Relapsing Forms of Multiple Sclerosis (RMS)CompletedNCT03277248Phase 3Results posted
• Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc)CompletedNCT03274076Phase 1/2Results posted
• A Study of Immune Phenotype Biomarkers in Patients With Relapsing Multiple Sclerosis (RMS) After Treatment With 0.5mg FingolimodCompletedNCT03257358Phase 4Results posted
• Telephone-Delivered Exercise for Multiple Sclerosis FatigueCompletedNCT03256851Not applicableResults posted
• Efficacy and Safety of Ofatumumab Compared to Placebo in Patients With Relapsing Multiple Sclerosis Followed by Extended Treatment With Open-label OfatumumabCompletedNCT03249714Phase 2Results posted
• Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple SclerosisCompletedNCT03232073Phase 3Results posted
• Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)TerminatedNCT03222973Phase 2Results posted
• Transcranial Direct Current Stimulation to Lower Neuropathic Pain in People With Multiple SclerosisTerminatedNCT03219073Not applicableResults posted
• Computer Assisted Cognitive Rehabilitation for Persons With Multiple SclerosisCompletedNCT03200899Not applicableResults posted
• COMparison Between All immunoTherapies for Multiple Sclerosis.CompletedNCT03193866Results posted
• Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple SclerosisCompletedNCT03185065Phase 3Results posted
• Fecal Microbial Transplantation in Relapsing Multiple Sclerosis PatientsTerminatedNCT03183869Phase 2Results posted
• Safety of Urate Elevation in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT03168711Phase 2Results posted
• Lipoic Acid for Progressive Multiple Sclerosis (MS)CompletedNCT03161028Phase 2Results posted
• A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT03160898Phase 2Results posted
• Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to OcrelizumabCompletedNCT03157830Results posted
• Sequential Natalizumab - Alemtuzumab Therapy in Patients With Relapsing Forms of Multiple SclerosisCompletedNCT03135249Phase 4Results posted
• AMX0035 in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT03127514Phase 2Results posted
• Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)TerminatedNCT03126760Phase 4Results posted
• Tele-Exercise and Multiple SclerosisCompletedNCT03117881Not applicableResults posted
• A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2CompletedNCT03093324Phase 3Results posted
• Scleroderma Patient-centered Intervention Network (SPIN) Hand Program Feasibility StudyCompletedNCT03092024Not applicableResults posted
• Recall Enhancement Through Treatment With Atomoxetine in MS (RETAIN-MS)CompletedNCT03091400Phase 2Results posted
• Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)TerminatedNCT03085810Phase 3Results posted
• Pembrolizumab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Hodgkin LymphomaActive, not recruitingNCT03077828Phase 2Results posted
• Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS)CompletedNCT03073603Phase 4Results posted
• Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS)TerminatedNCT03068754Phase 2/3Results posted
• Light Therapy as Treatment for Fatigue in Multiple SclerosisCompletedNCT03060759Not applicableResults posted
• Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis PatientsCompletedNCT03060551Early Phase 1Results posted
• Natalizumab in Preventing Post-partum Relapses in Multiple SclerosisCompletedNCT03046251Phase 4Results posted
• Proof of Mechanism Study of GSK2330811 in Diffuse Cutaneous Systemic SclerosisCompletedNCT03041025Phase 2Results posted
• Intranasal Insulin for Improving Cognitive Function in Multiple SclerosisCompletedNCT02988401Phase 1/2Results posted
• Dimethyl Fumarate (DMF) in Systemic Sclerosis-Associated Pulmonary Arterial HypertensionTerminatedNCT02981082Phase 1Results posted
• Safety of Switching From Rituximab to Ocrelizumab in MS PatientsCompletedNCT02980042Phase 3Results posted
• A Study of Efficacy and Safety of M2951 in Participants With Relapsing Multiple SclerosisTerminatedNCT02975349Phase 2Results posted
• MEasuring Satisfaction of Treatment With REbif After Initial Treatment of Multiple Sclerosis (MS)TerminatedNCT02949908Results posted
• Evaluating of the Effect of Fingolimod With Fish Oil on Relapsing-Remitting Multiple Sclerosis PatientsCompletedNCT02939079Phase 2/3Results posted
• A Study for Patients Who Completed VITALITY-ALS (CY 4031)CompletedNCT02936635Phase 3Results posted
• Effect of MD1003 in Progressive Multiple Sclerosis (SPI2)TerminatedNCT02936037Phase 3Results posted
• Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic SclerosisCompletedNCT02921971Phase 2Results posted
• Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)TerminatedNCT02907177Phase 3Results posted
• Medical Marijuana and Its Effects on Motor Function in People With Multiple SclerosisCompletedNCT02898974Results posted
• Efficacy and Safety of Daclizumab in Participants With RRMS Switching From NatalizumabTerminatedNCT02881567Phase 3Results posted
• Ablative Fractional Laser for Sclerotic GVHD-Associated Joint ContracturesTerminatedNCT02881047Not applicableResults posted
• Efficacy and Safety of Plasma Exchange With Albutein® 5% in Participants With Amyotrophic Lateral SclerosisCompletedNCT02872142Phase 2Results posted
• A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT)CompletedNCT02861014Phase 3Results posted
• Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis ComplexCompletedNCT02849457Phase 2Results posted
• A Pragmatic Trial of Dietary Programs in People With Multiple Sclerosis (MS)CompletedNCT02846558Not applicableResults posted
• Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis.CompletedNCT02792231Phase 3Results posted
• Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple SclerosisCompletedNCT02792218Phase 3Results posted
• Mexiletine in Sporadic Amyotrophic Lateral SclerosisCompletedNCT02781454Phase 2Results posted
• Novel Portable Diagnostic Device for Automatic Detection of Relative Afferent Pupillary DefectCompletedNCT02772666Not applicableResults posted
• Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A Safety and Dose Finding StudyCompletedNCT02760056Phase 1Results posted
• Abituzumab in SSc-ILDTerminatedNCT02745145Phase 2Results posted

← Sclerosis overview